Cargando…

KRAS Mutation as a Potential Prognostic Biomarker of Biliary Tract Cancers

BACKGROUND: The aim of this study was to identify the unique molecular characteristics of biliary tract cancer (BTC) for the development of novel molecular-targeted therapies. MATERIALS AND METHODS: We performed mutational analysis of KRAS, BRAF, PIK3CA, and FBXW7 and immunohistochemical analysis of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yokoyama, Masaaki, Ohnishi, Hiroaki, Ohtsuka, Kouki, Matsushima, Satsuki, Ohkura, Yasuo, Furuse, Junji, Watanabe, Takashi, Mori, Toshiyuki, Sugiyama, Masanori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156551/ https://www.ncbi.nlm.nih.gov/pubmed/28008299 http://dx.doi.org/10.4137/JCM.S40549

Ejemplares similares

Overexpression of MET is a new predictive marker for anti-EGFR therapy in metastatic colorectal cancer with wild-type KRAS
por: Kishiki, Tomokazu, et al.
Publicado: (2014)

A rad50 germline mutation induces tumorigenesis and ataxia-telangiectasia phenotype in a transparent medaka model
por: Chisada, Shinichi, et al.
Publicado: (2023)

A pathological complete response after combined chemotherapy of gemcitabine and S-1 in advanced biliary tract cancer with para-aortic lymph nodes metastasis: a case report
por: Watanabe, Takeshi, et al.
Publicado: (2017)

Predisposition to Lung Adenocarcinoma in a Family Harboring the Germline EGFR V843I Mutation
por: Ohtsuka, Kouki, et al.
Publicado: (2019)

Can Individuals with Suboptimal Antibody Responses to Conventional Antiviral Vaccines Acquire Adequate Antibodies from SARS-CoV-2 mRNA Vaccination?
por: Ogura, Wataru, et al.
Publicado: (2022)

Targeted Therapy for Biliary Tract Cancer
por: Furuse, Junji, et al.
Publicado: (2011)

Whole-Genome Sequence of Mycobacterium kyorinense
por: Ohtsuka, Kouki, et al.
Publicado: (2014)

A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer
por: Suzuki, Eiichiro, et al.
Publicado: (2013)

Preoperative biliary drainage for biliary tract and ampullary carcinomas
por: Nagino, Masato, et al.
Publicado: (2008)

Oncogenic KRAS–expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice
por: Kasuga, Akiyoshi, et al.
Publicado: (2021)

The efficacy of immune checkpoint inhibitors in biliary tract cancer with KRAS mutation
por: Jeong, Sun Young, et al.
Publicado: (2023)

Diagnosis of biliary tract and ampullary carcinomas
por: Tsukada, Kazuhiro, et al.
Publicado: (2008)

Use of a plasma test for verifying epidermal growth factor receptor gene (EGFR) mutations in fluid samples from non-small cell lung cancer patients()
por: Ogura, Wataru, et al.
Publicado: (2020)

Guidelines for chemotherapy of biliary tract and ampullary carcinomas
por: Furuse, Junji, et al.
Publicado: (2008)

Flowcharts for the management of biliary tract and ampullary carcinomas
por: Miyakawa, Shuichi, et al.
Publicado: (2008)

Radiation therapy and photodynamic therapy for biliary tract and ampullary carcinomas
por: Saito, Hiroya, et al.
Publicado: (2008)

Establishing an internal quality control method for the stable extraction of nucleic acids of severe acute respiratory syndrome coronavirus 2 and RT‐PCR‐based detection
por: Okuyama, Takahiro, et al.
Publicado: (2021)

Comparison of guidewires for successful cannulation of biliary stenosis and targeting of biliary branches in ERCP
por: Kobayashi, Masanori, et al.
Publicado: (2023)

Clinical implication of surgical resection for recurrent biliary tract cancer: Does it work or not?
por: Miyazaki, Masaru, et al.
Publicado: (2017)

Serum levels of candidate microRNA diagnostic markers differ among the stages of non-small-cell lung cancer
por: Aiso, Toshiko, et al.
Publicado: (2018)

Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment
por: Kondo, Satoshi, et al.
Publicado: (2008)

Risk factors for biliary tract and ampullary carcinomas and prophylactic surgery for these factors
por: Miyazaki, Masaru, et al.
Publicado: (2008)

Stenting and interventional radiology for obstructive jaundice in patients with unresectable biliary tract carcinomas
por: Tsuyuguchi, Toshio, et al.
Publicado: (2008)

Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine
por: Ikeda, Masafumi, et al.
Publicado: (2017)

Purpose, use, and preparation of clinical practice guidelines for the management of biliary tract and ampullary carcinomas
por: Takada, Tadahiro, et al.
Publicado: (2008)

Chemotherapy for Biliary Tract Cancer in 2021
por: Sasaki, Takashi, et al.
Publicado: (2021)

Current progress in perioperative chemotherapy for biliary tract cancer
por: Ioka, Tatsuya, et al.
Publicado: (2023)

Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer
por: Hezel, A F, et al.
Publicado: (2014)

Metabolomics of Duodenal Juice for Biliary Tract Cancer Diagnosis
por: Kishi, Kazuma, et al.
Publicado: (2023)

Essential updates to the surgical treatment of biliary tract cancer
por: Matsukuma, Satoshi, et al.
Publicado: (2019)

BILIARY TRACT DISORDERS
Publicado: (1984)

Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case report
por: Matsuki, Ryota, et al.
Publicado: (2018)

Pathologies of Precursor Lesions of Biliary Tract Carcinoma
por: Nakanuma, Yasuni, et al.
Publicado: (2022)

Dysbiosis of the Fecal and Biliary Microbiota in Biliary Tract Cancer
por: Ito, Zensho, et al.
Publicado: (2022)

The role of Kras and canonical Wnt pathways for tumorigenesis of extrahepatic biliary system
por: Nagao, Munemasa, et al.
Publicado: (2023)

BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer
por: Nakashima, Shinsuke, et al.
Publicado: (2015)

Endoscopic inside stent placement is suitable as a bridging treatment for preoperative biliary tract cancer
por: Kobayashi, Noritoshi, et al.
Publicado: (2015)

Main causes of death in advanced biliary tract cancer
por: Kimura‐Seto, Kana, et al.
Publicado: (2023)

The efficacy of biliary and serum macrophage inhibitory cytokine-1 for diagnosing biliary tract cancer
por: Sugimoto, Mitsuru, et al.
Publicado: (2017)

Diseases of the liver and biliary tract /
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_c0ea7790p0db3h5ijeptt1s78o